Department of Oncology Laboratories, Weatherall Institute of Molecular Medicine, Oxford, United Kingdom.
Radiother Oncol. 2012 Jun;103(3):402-9. doi: 10.1016/j.radonc.2012.03.009. Epub 2012 Apr 30.
IGF-1R depletion sensitizes prostate cancer cells to ionizing radiation and DNA-damaging cytotoxic drugs. This study investigated the hypothesis that IGF-1R regulates DNA double strand break (DSB) repair.
We tested effects of IGF-1R siRNA transfection on the repair of radiation-induced DSBs by immunoblotting and immunofluorescence for γH2AX, and pulsed-field gel electrophoresis. Homologous recombination (HR) was quantified by reporter assays, and cell cycle distribution by flow cytometry.
We confirmed that IGF-1R depletion sensitized DU145 and PC3 prostate cancer cells to ionizing radiation. DU145 control transfectants resolved radiation-induced DSBs within 24 h, while IGF-1R depleted cells contained 30-40% unrepaired breaks at 24 h. IGF-1R depletion induced significant reduction in DSB repair by HR, although the magnitude of the repair defect suggests additional contributory factors. Radiation-induced G2-M arrest was attenuated by IGF-1R depletion, potentially suppressing cell cycle-dependent processes required for HR. In contrast, IGF-1R depletion induced only minor radiosensitization in LNCaP cells, and did not influence repair. Cell cycle profiles were similar to DU145, so were unlikely to account for differences in repair responses.
These data indicate a role for IGF-1R in DSB repair, at least in part via HR, and support use of IGF-1R inhibitors with DNA damaging cancer treatments.
IGF-1R 耗竭使前列腺癌细胞对电离辐射和 DNA 损伤细胞毒性药物敏感。本研究旨在验证 IGF-1R 是否调节 DNA 双链断裂(DSB)修复。
通过免疫印迹法和γH2AX 的免疫荧光法,脉冲场凝胶电泳检测 IGF-1R siRNA 转染对辐射诱导的 DSB 修复的影响。通过报告基因检测同源重组(HR),流式细胞术检测细胞周期分布。
我们证实 IGF-1R 耗竭使 DU145 和 PC3 前列腺癌细胞对电离辐射更加敏感。DU145 对照转染细胞在 24 小时内修复了辐射诱导的 DSB,而 IGF-1R 耗尽的细胞在 24 小时时仍有 30-40%的未修复断裂。IGF-1R 耗竭显著降低了 HR 介导的 DSB 修复,尽管修复缺陷的程度表明还有其他促成因素。IGF-1R 耗竭削弱了辐射诱导的 G2-M 期阻滞,可能抑制了 HR 所需的细胞周期依赖性过程。相比之下,IGF-1R 耗竭仅使 LNCaP 细胞轻微放射增敏,不影响修复。细胞周期谱与 DU145 相似,因此不太可能解释修复反应的差异。
这些数据表明 IGF-1R 在 DSB 修复中起作用,至少部分是通过 HR 起作用,并支持在 DNA 损伤性癌症治疗中使用 IGF-1R 抑制剂。